Estrella Immunopharma, Inc. (ESLA) Year-over-year earnings per share growth for the last twelve months

Estrella Immunopharma - graphic logo of issuer ESLA

Estrella Immunopharma is collaborating with laboratories and physicians to find ways to combat resistant tumors. The quarterly net income per share growth trend on the GURU.Markets chart demonstrates a pivot driven by alliances with oncology centers for drug launches and the active development of the safe ARTEMIS T-cell therapy. The value of 64.70 shows the latest reading of this metric.

estrellabio.com (ESLA) - Year-over-year earnings per share growth for the last 12 months from 02/21/2024 to 11/17/2026

Summary analytical data breakdowns for Estrella Immunopharma, Inc. (ESLA)

- market value and analyst target forecast:
Fundamental company valuation:Estrella Immunopharma
Manufactured product of estrellabio.com

For Estrella Immunopharma (ESLA), which faces the risk of R&D failure in blood cancer therapy amid a lack of revenue, this indicator serves as a measure of capital management efficiency. By analyzing the history of quarterly EPS changes, an investor assesses the trend of net profit per share, separating real financial stability from speculative noise and determining the probability of future cash flows in a highly competitive environment.

Who Estrella Immunopharma competes with

tgtherapeutics.com (TGTX) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Arcellx Therapeutics (ACLX)|Year-over-year earnings per share growth for the last twelve months Disc Medicine Inc|Earnings per share growth in annualized terms for the last twelve months Syndax Pharmaceuticals SNDX|Quarterly EPS earnings growth KURA|ADC Therapeutics SA - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth FHTX (Foghorn Therapeutics, Inc.)|Vor Bio Inc. (VOR) - Earnings per share growth in annualized terms for the last twelve months|NKTX - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months coeptistx.com|ATNM (Actinium Pharmaceuticals) - Year-over-year net earnings per share growth for the last 12 months|CASI - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Marker Bio|Quarterly EPS earnings growth IN8bio, Inc.|Year-over-year earnings per share growth for the last twelve months Eterna Therapeutics Inc (ERNA)|Year-over-year net earnings per share change for the last twelve months gtbiopharma.com|Quarterly EPS earnings growth APTO (Aptose Biosciences)|Quarterly EPS earnings growth Bio-Path BPTH|MEI Pharma Inc - Quarterly EPS earnings growth|VINC (Vincerx Pharma Inc.) - Year-over-year earnings per share growth for the last 12 months